400 likes | 936 Views
Disclosures. . Speakers Bureau/ Honoraria : GlaxoSmithKline, AstraZeneca lamotrigine (Lamictal) quetiapine (Seroquel)PsychEducation.org -- free, no data storage;
E N D
1. Bipolar Disorder: Detection and Management in Primary Care
2. Disclosures
3. Cain et al, 2005 The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest
4. Diagnosis
Screen everyone before antidepressants because they can cause:
Switch to mania
Rapid cycling
Rx-resistance
Suicide
(And FDA says so
)
Tools: Bipolarity Index, MoodCheck, PsychEducation.org
Treatment
Non-medication components of treatment
substance use / regular sleep pattern
psychotherapy: stress management, support
bipolar-specific therapies
Mood stabilizers (with antidepressant effects)
9 antidepressants that arent antidepressants
5. Diagnosis
Screen everyone before antidepressants because they can cause:
Switch to mania
Rapid cycling
Rx-resistance
Suicide
(And FDA says so
)
Tools: Bipolarity Index, MoodCheck, PsychEducation.org
Treatment
Non-medication components of treatment
substance use / regular sleep pattern
psychotherapy: stress management, support
bipolar-specific therapies
Mood stabilizers (with antidepressant effects)
9 antidepressants that arent antidepressants
11. Time Symptomatic
13. Mood Spectrum
14. Mood Spectrum
16. Bipolarity Index How bipolar are you?
17. Bipolarity Index How bipolar are you? Hypomania/Mania 20 points
Family History 20 points
Age of (Mood) Onset 20 points
Course of Illness 20 points
Response to Rx 20 points
18. Diagnosis
Screen everyone before antidepressants because they can cause:
Switch to mania
Rapid cycling
Rx-resistance
Suicide
(And FDA says so
)
Tools: Bipolarity Index, MoodCheck, PsychEducation.org
Treatment
Non-medication components of treatment
substance use / regular sleep pattern
psychotherapy: stress management, support
bipolar-specific therapies
Mood stabilizers (with antidepressant effects)
9 antidepressants that arent antidepressants
19. Bipolar Screening Mood Disorders Questionnaire
- Better for Bipolar I
- Now copyrighted
21. Diagnosis
Screen everyone before antidepressants because they can cause:
Switch to mania
Rapid cycling
Rx-resistance
Suicide
(And FDA says so
)
Tools: Bipolarity Index, MoodCheck, PsychEducation.org
Treatment
Non-medication components of treatment
substance use / regular sleep pattern
psychotherapy: stress management, support
bipolar-specific therapies
Mood stabilizers (with antidepressant effects)
9 antidepressants that arent antidepressants
22. Diagnosis
Over or under-diagnosis?
FDA: Screen for Bipolar
Beyond the DSM-IV: non-manic bipolar markers
Tools: Bipolarity Index, PsychEducation.org, MoodCheck
Treatment
Non-medication components of treatment
substance use / regular sleep pattern
psychotherapy: stress mgmt, support
bipolar-specific therapies
Mood stabilizers (with antidepressant effects)
Antidepressants in bipolar depression?
9 antidepressants that arent antidepressants
24. Diagnosis
Over or under-diagnosis?
FDA: Screen for Bipolar
Beyond the DSM-IV: non-manic bipolar markers
Tools: Bipolarity Index, PsychEducation.org, MoodCheck
Treatment
Non-medication components of treatment
substance use / regular sleep pattern
psychotherapy: stress mgmt, support
bipolar-specific therapies
Mood stabilizers (with antidepressant effects)
Antidepressants in bipolar depression?
9 antidepressants that arent antidepressants
28. Diagnosis
Screen everyone before antidepressants because they can cause:
Switch to mania
Rapid cycling
Rx-resistance
Suicide
(And FDA says so
)
Tools: Bipolarity Index, MoodCheck, PsychEducation.org
Treatment
Non-medication components of treatment
substance use / regular sleep pattern
psychotherapy: stress management, support
bipolar-specific therapies
Mood stabilizers (with antidepressant effects)
9 antidepressants that arent antidepressants
29. Disclosures
30. TIMA Bipolar: Treatment of Acute Depressive Episodes (Stages 12)
This slide represents the algorithm developed through the Texas Implementation of Medication Algorithms initiative for depressive episodes in patients with bipolar I disorder.
This particular algorithm is a standalone guideline, distinct from those for treating patients with mania, hypomania, or mixed episodes. Depression treatments were ordered with the least likelihood of causing mood destabilization.
Stage 1 has multiple entry points. All patients with bipolar disorder who are currently depressed should have mood stabilizer treatment (eg, lithium) optimized before initiation of antidepressants. If depressive symptoms persist after mood stabilizer treatment is optimized, lamotrigine (LTG) should be added. LTG should be used as monotherapy only in patients with no history of severe and/or recent mania.
Stage 2 options include olanzapine-fluoxetine combination treatment and atypical antipsychotics with evidence of antidepressive activity.
After partial response or nonresponse after stage 2, further medical consult or referral for other treatment options is suggested.
Reference
Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005;66:870-886.
TIMA Bipolar: Treatment of Acute Depressive Episodes (Stages 12)
This slide represents the algorithm developed through the Texas Implementation of Medication Algorithms initiative for depressive episodes in patients with bipolar I disorder.
This particular algorithm is a standalone guideline, distinct from those for treating patients with mania, hypomania, or mixed episodes. Depression treatments were ordered with the least likelihood of causing mood destabilization.
Stage 1 has multiple entry points. All patients with bipolar disorder who are currently depressed should have mood stabilizer treatment (eg, lithium) optimized before initiation of antidepressants. If depressive symptoms persist after mood stabilizer treatment is optimized, lamotrigine (LTG) should be added. LTG should be used as monotherapy only in patients with no history of severe and/or recent mania.
Stage 2 options include olanzapine-fluoxetine combination treatment and atypical antipsychotics with evidence of antidepressive activity.
After partial response or nonresponse after stage 2, further medical consult or referral for other treatment options is suggested.
Reference
Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005;66:870-886.
31. Texas Bipolar Depression Algorithm TIMA Bipolar: Treatment of Acute Depressive Episodes (Stages 12)
This slide represents the algorithm developed through the Texas Implementation of Medication Algorithms initiative for depressive episodes in patients with bipolar I disorder.
This particular algorithm is a standalone guideline, distinct from those for treating patients with mania, hypomania, or mixed episodes. Depression treatments were ordered with the least likelihood of causing mood destabilization.
Stage 1 has multiple entry points. All patients with bipolar disorder who are currently depressed should have mood stabilizer treatment (eg, lithium) optimized before initiation of antidepressants. If depressive symptoms persist after mood stabilizer treatment is optimized, lamotrigine (LTG) should be added. LTG should be used as monotherapy only in patients with no history of severe and/or recent mania.
Stage 2 options include olanzapine-fluoxetine combination treatment and atypical antipsychotics with evidence of antidepressive activity.
After partial response or nonresponse after stage 2, further medical consult or referral for other treatment options is suggested.
Reference
Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005;66:870-886.
TIMA Bipolar: Treatment of Acute Depressive Episodes (Stages 12)
This slide represents the algorithm developed through the Texas Implementation of Medication Algorithms initiative for depressive episodes in patients with bipolar I disorder.
This particular algorithm is a standalone guideline, distinct from those for treating patients with mania, hypomania, or mixed episodes. Depression treatments were ordered with the least likelihood of causing mood destabilization.
Stage 1 has multiple entry points. All patients with bipolar disorder who are currently depressed should have mood stabilizer treatment (eg, lithium) optimized before initiation of antidepressants. If depressive symptoms persist after mood stabilizer treatment is optimized, lamotrigine (LTG) should be added. LTG should be used as monotherapy only in patients with no history of severe and/or recent mania.
Stage 2 options include olanzapine-fluoxetine combination treatment and atypical antipsychotics with evidence of antidepressive activity.
After partial response or nonresponse after stage 2, further medical consult or referral for other treatment options is suggested.
Reference
Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005;66:870-886.
32. Lamotrigine: Rash Onset
33. (Vulcan Thumb)
35. Diagnosis
Screen everyone before antidepressants because they can cause:
Switch to mania
Rapid cycling
Rx-resistance
Suicide
(And FDA says so
)
Tools: Bipolarity Index, MoodCheck, PsychEducation.org
Treatment
Non-medication components of treatment
substance use / regular sleep pattern
psychotherapy: stress management, support
bipolar-specific therapies
Mood stabilizers (with antidepressant effects)
9 antidepressants that arent antidepressants
36. 1. Cause switching? How often?
2. Mood destabilization
a) Cause rapid cycling, mixed states b) Prevent stabilization?
c) Cause kindling?
3. Already on, and a mood stabilizer, and doing well when to taper off? Leave on?
37. 1. Cause switching? How often?
2. Mood destabilization
a) Cause rapid cycling, mixed states b) Prevent stabilization?
c) Cause kindling?
3. Already on, and a mood stabilizer, and doing well when to taper off? Leave on?